• 공업화학
• /
• 제34권2호
• /
• pp.186-191
• /
• 2023

The goal of this study was to use gelatin to modify the surface of fibroin microspheres to enhance their biofunctionality for tissue engineering and regenerative medicine applications. Three different methods were used for the modification: coating, incorporation, and covalent bonding. Wound-healing assays demonstrated that gelatin modification of fibroin microspheres enhances 3T3 and HDF cell migration. Although the level of gelatin coverage varied depending on the method used, there was no significant difference between the modified microspheres. The gelatin-modified microspheres also increased the migration velocity of individual 3T3 cells. The results suggest that gelatin modification of fibroin microspheres is a promising approach for developing functional biomaterials with enhanced biological properties. Further optimization of gelatin modification is necessary to maximize the biofunctionality of fibroin microspheres.

• Archives of Pharmacal Research
• /
• 제10권1호
• /
• pp.42-49
• /
• 1987

This study is to evaluate the potential use of aclarubicin-loaded gelatin microspheres as an intravascular biodegradable drug delivery system for the regional cancer therapy. The diameter of the microspheres prepared by water in oil emulsion polymerization could be controlled by adjusting the stirring rate in the range of 10-50 $\mu$m : D(in $\mu$m) = -73.8 log (rpm) + 262.7. The addition of proteolytic enzyme increased the in vitro aclarubicin release but it did not change the amount of the initial burst release which reached about 45%. Microspheres injected intravenously into the mouse tail vein embolized only to the lung when observed by fluorescence microscopy. From histological examination following injection of gelatin microspheres into mouse femoral muscle, mild inflammation was observed from the appearance of neutrophils after 2 days and rapid repair process was confirmed thereafter. Biodegradation process of gelatin microspheres lodged on the pulmonary capillary bed was followed up by microscopic observation; degradation was taking place by about 36 hrs, followed by severe damage on the spheerical shape and microspheres was no longer found 10 days after injection.

• Archives of Pharmacal Research
• /
• 제9권3호
• /
• pp.145-152
• /
• 1986

Magnetically reponsive gelatin microspheres for the targeting of drugs have been prepared using a water-in-oil emulsion technique with chemical cross-linking of the protein. The manufacturing variables affecting microsphere size, size distribution and surface characteristics have been examined as well as the magnetic responsiveness in vitro. Sesame oil was utilized for non-aqueous phase and magentic gelatin microspheres of different size from 1. 89 to 14.88 $\mu\textrm{m}$ in mean diameter could be obtained with variation of HLB values of non-ionic surfactants. The content of magnetite which uniformly distributed throughout the microspheres was 26.7% (w/w). It was possible to control the localization of magnetic gelatin microspheres at specific sites within capilary models by using external magnetic field of under 5K gauss.

• Journal of Pharmaceutical Investigation
• /
• 제40권4호
• /
• pp.245-250
• /
• 2010

Porous poly(lactic-co-glycolic acid) microspheres (PLGA MS) have been utilized as an inhalation delivery system and a matrix scaffold system for tissue engineering. Here, gelatin (type A) is introduced as an extractable pH-responsive porogen, which is capable of controlling the porosity and pore size of PLGA microspheres. Porous PLGA microspheres were prepared by a water-in-oil-in-water ($w_1/o/w_2$) double emulsification/solvent evaporation method. The surface morphology of these microspheres was examined by varying pH (2.0~11.0) of water phases, using scanning electron microscopy (SEM). Also, their porosity and pore size were monitored by altering acidification time (1~5 h) using a phosphoric acid solution. Results showed that the pore-forming capability of gelatin was optimized at pH 5.0, and that the surface pore-formation was not significantly observed at pHs of < 4.0 or > 8.0. This was attributable to the balance between gel-formation by electrostatic repulsion and dissolution of gelatin. The appropriate time-selection between PLGA hardening and gelatin-washing out was considered as a second significant factor to control the porosity. Delaying the acidification time to ~5 h after emulsification was clearly effective to make pores in the microspheres. This finding suggests that the porosity and pore size of porous microspheres using gelatin can be significantly controlled depending on water phase pH and gelatin-removal time. The results obtained in this study would provide valuable pharmaceutical information to prepare porous PLGA MS, which is required to control the porosity.

• 공업화학
• /
• 제24권5호
• /
• pp.471-475
• /
• 2013

이 연구는 젤라틴-신남산 접합체를 알긴산나트륨 마이크로스피어에 코팅하여 광 민감성 마이크로스피어를 제조하여 광 민감성을 관찰하였다. 광 민감성 마이크로스피어는 W/O (water-in-oil) 에멀젼법을 이용하여 알긴산나트륨 마이크로스피어를 만든 후 젤라틴-신남산 접합체를 알긴산나트륨 마이크로스피어 표면에 코팅시켜 제조하였다. 젤라틴-신남산 접합체의 합성은 젤라틴의 아미노 그룹과 신남산의 카복실 그룹 사이의 아미드화반응으로 결합하였다. 알긴산나트륨 마이크로스피어 표면의 젤라틴-신남산 접합체의 코팅은 SEM-EDS의 결과로 확인하였다. 또한 형성된 접합체에 결합된 신남산의 흡광도를 측정하여 알긴산나트륨 1 g당 젤라틴-신남산 접합체가 0.13 g이 코팅된 것을 확인했다. 코팅된 마이크로스피어를 SEM을 통해 마이크로스피어의 크기가 $10{\mu}m$인 것을 확인했다. 광 민감성의 관찰을 위해 365 nm와 254 nm 파장의 자외선을 조사하여 이량화 정도를 측정한 결과 이량화 정도가 49%와 28%였다. 마이크로스피어의 방출경향을 관찰하기 위해 모델약물로 FITC-dextran을 사용하여 알긴산나트륨 마이크로스피어에 봉입하여 방출실험을 진행하였고 그 결과 약 42%의 FITC-dextran이 방출되었다. 결과적으로 젤라틴-신남산 접합체가 코팅된 마이크로스피어는 광 반응성을 가지는 약물전달체로 사용될 수 있을 것이다.

• Journal of Pharmaceutical Investigation
• /
• 제26권4호
• /
• pp.273-280
• /
• 1996

Chondroitin sulfate/gelatin microspheres containing dexamethasone 21-acetate were prepared by complex coacervation method and their release patterns were examined in vitro. Microspheres prepared with a small amount of crosslinking agent had smooth surface and few pores, but those with a large amount of crosslinking agent were more porous and less spherical. In vitro release patterns were varied by changing polymer/drug weight ratio and amount of crosslinking agent. The release rate of dexamethasone 21-acetate in the presence of collagenase was faster than that in the absence of collagenase. Anti-inflammatory effect of dexamethasone 21-acetate microspheres was more efficient than that of dexamethasone 21-acetate solution in carrageenan-induced arthritis in the rat. On the basis of the above results, we might expect the degradation and drug release rate of these microspheres to be regulated by the degree of crosslinking and the level of enzymes. In patients with severe rheumatoid arthritis who have high concentration of collagenase, more drug would be released from the microspheres. An intra-articular injection therapy of rheumatoid arthritis with desired release kinetics could be developed to enhance patient compliance and therapeutic index.

• Archives of Pharmacal Research
• /
• 제29권7호
• /
• pp.598-604
• /
• 2006

In many conventional drug delivery systems in vogue, failure to deliver efficient drug delivery at the target site/organs; is evident as a result, less efficacious pharmacological response is elicited. Microspheres can be derived a remedial measure which can improve site-specific drug delivery to a considerable extent. As an application, Lung-targeting Ofloxacin-loaded gelatin microspheres (GLOME) were prepared by water in oil emulsion method. The Central Composite Design (CCD) was used to optimize the process of preparation, the appearance and size distribution were examined by scanning electron microscopy, the aspects such as in vitro release characteristics, stability, drug loading, loading efficiency, pharmacokinetics and tissue distribution in albino mice were studied. The experimental results showed that the microspheres in the range of $0.32-22\;{\mu}m$. The drug loading and loading efficiency were 61.05 and 91.55% respectively. The in vitro release profile of the microspheres matched the korsmeyer’s peppas release pattern, and release at 1h was 42%, while for the original drug, ofloxacin under the same conditions 90.02% released in the first half an hour. After i.v. administration (15 min), the drug concentration of microspheres group in lung in albino mice was $1048\;{\mu}g/g$, while that of controlled group was $6.77\;{\mu}g/g$. GLOME found to release the drug to a maximum extent in the target tissue, lungs.

• 청정기술
• /
• 제12권4호
• /
• pp.205-210
• /
• 2006

본 연구에서는 폐 polystyrene을 재활용하기 위한 방법으로, 최적의 정제조건을 확립한 다음, 이를 활용하여 부가가치가 높은 Polystyrene 중공 미세구를 제조하고자 하였다. 회수된 PS를 이용하여 다중유화법($W_1/O/W_2$)에 의해 PS/PVA 두층을 갖는 중공 미세구를 얻을 수 있었다. 1단계 반응인 $W_1/O$ emulsion 생성 시 초음파처리는 입자 크기와 분포를 조절하는데 중요한 인자로 작용하였으며, 20초 처리하였을 때 평균입자크기 $1.35{\mu}m$, 입도분포 $0.8{\mu}m{\sim}2.8{\mu}m$인 고분자 중공 미세구를 제조할 수 있었다. 또한 $W_2$상 계면활성제로 gelatin 또는 Tween 80을 사용하였을 때 상대적으로 입자 크기도 작고 균일한 고분자 중공 미세구를 제조할 수 있었다.

• 폴리머
• /
• 제24권5호
• /
• pp.728-735
• /
• 2000

지속적인 국소 마취의 가능성을 연구하기 위하여 펜타닐이 함유된 생분해성 poly(L-lactide-glycolide) (75 : 25 락타이드와 글리콜라이드의 몰 비, PLGA) 미립구를 제조하였다. 펜타닐 베이스가 함유된 PLGA 미립구는 일반적인 O/W 용매 증발법으로 제조하였으며 미립구의 크기는 10에서 150 $\mu\textrm{m}$의 범위에 있었다. 미립구의 표면과 단면 형태를 전자현미경으로 관찰하였고 생체외 펜타닐 베이스 방출량은 HPLC로 분석하였다. 젤라틴 유화제의 사용으로 가장 낮은 다공성 단면의 형태와 가장 높은 포접율을 가질 수 있었다. 펜타닐의 방출 패턴은 유화제의 종류, PLGA의 분자량 및 농도, 초기 약물 loading양 등과 같은 제조 조건들의 영향이 미치는 것으로 관찰되었다. 생체외에서 펜타닐 베이스의 방출은 제조 조건을 조절함으로써 거의 zero-order 형태로 25일 이상으로 지속적이었다. 또한 XRD와 DSC로 펜타닐이 함유된 PLGA 미립구의 물리화학적인 성질을 조사하였다.

• 폴리머
• /
• 제27권1호
• /
• pp.9-16
• /
• 2003

골다공증 치료제 이프리플라본 (IP)은 조골세포의 분화와 증식을 자극하고 에스트로겐의 존재로 칼시토닌 분비를 강화한다. 조절 가능한 생분해성과 생체적합성으로 인하여 락타이드-글라이콜라이드 공중합체 (PLGA)는 약물방출조절을 연구하는데 가장 적합한 고분자중의 하나이다. 본 연구에서 IP가 함유된 PLGA 미립구는 일반적인 O/W 용매 증발법으로 제조하였으며, 미립구의 크기는 5~200 $mu extrm{m}$의 범위에 있었다. 미립구의 형태는 SEM으로 관찰하였고, 생체외 방출실험에서 IP 방출량은 HPLC로 분석 하였다. 젤라틴 및 PVA등의 유화제 사용으로 가장 높은 약물 포접율을 얻을 수 있었다. 미립구의 형태, 크기 및 약물 방출 패턴은 PLGA의 분자량 (8, 20, 33 및 90 kg/mol), 고분자용액의 농도 (2.5, 5, 10 및 20%), 유화제의 종류 (PVA, gelatin 및 Tween 80), 초기 약물 함유량 (5, 10, 20 및 30%) 및 교반속도 (250, 500 및 1000 rpm) 등과 같은 여러 제조 변수들에 의하여 조절할 수 있음을 알 수 있었다. 생체외 방출실험에서 IP 방출은 제조조건을 조절함으로써 거의 영차방출 형태로 30일 이상으로 지속적이었다 또한, XRD와 DSC로 IP 함유 PLGA 미립구의 물리화학적인 성질을 조사하여 방출메카니즘을 고찰하였다.